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X-ray crystallography is an experimental technique that 
is used to determine three-dimensional structures of 
(biological) macromolecules crystallized in an orderly 
manner. As crystal structures provide visual models, 
which are typically used to interpret experimental data 
and generate new mechanistic hypotheses, it is essen-
tial that the limitations of crystal structures be carefully 
taken into account when making interpretations. The 
quality of the collected x-ray diffraction data are crucial 
for building a correct structural model. Without evalua-
tion of the underlying crystallographic data, the use of 
deposited models could lead to erroneous conclusions 
of mechanistic features of the proteins.
Here we focus on the progress in crystallographic 
studies of the glutamate transporter family to illustrate 
to what extent mechanistic features can be reliably ex-
tracted from the crystallographic models. Glutamate 
transporters are an important family of secondary active 
transporters. In mammals, they play a crucial role in pre-
venting neurotoxicity, by effecting reuptake of the neu-
rotransmitter glutamate from the synaptic cleft. More 
than 20 structures of glutamate transporters in different 
conformational states have been determined, most of 
which have been obtained at medium resolution, pro-
ducing models of rather moderate quality, with the in-
herent risk of over-interpretation. In this viewpoint, we 
inspect the crystallographic data and show that the use 
of the derived models could lead to erroneous conclu-
sions of mechanistic features of the proteins. We under-
score the importance of obtaining high-resolution and 
high-quality crystal structures for understanding the 
transport mechanism in detail.
Glutamate transporters
Glutamate transporters belong to a large family of sec-
ondary active transporters that catalyze uptake of acidic 
amino acids, neutral amino acids, or dicarboxylic acids 
in prokaryotes and eukaryotes (Slotboom et al., 1999; 
Vandenberg and Ryan, 2013; Grewer et al., 2014). Mam-
malian glutamate transporters, also called excitatory 
amino acid transporters (EAATs), play a key role in 
neuronal signaling by clearing excess neurotransmitter 
glutamate from the presynaptic cleft. EAATs couple glu-
tamate uptake to symport of three sodium ions and one 
proton and to antiport of one potassium ion (Zerangue 
and Kavanaugh, 1996; Fig. 1). In Bacteria and Archaea, 
glutamate transporter homologues catalyze uptake of 
glutamate and aspartate as nutrients. These proteins 
are either proton- or sodium ion–dependent transport-
ers and do not require potassium ions for transport 
(Tolner et al., 1995; Gaillard et al., 1996; Slotboom et 
al., 1999; Ryan et al., 2009).
Until recently, crystal structures were available only 
for glutamate transporter homologues from the Ar-
chaea Pyrococcus horikoshii (GltPh) and Thermococcus 
kodakarensis (GltTk; Table 1; Yernool et al., 2004; Boud-
ker et al., 2007; Reyes et al., 2009, 2013; Verdon and 
Boudker, 2012; Jensen et al., 2013; Verdon et al., 2014; 
Akyuz et al., 2015; Guskov et al., 2016). Both GltPh and 
GltTk cotransport aspartate with three sodium ions and, 
in contrast to human EAATs, use neither proton nor 
potassium gradients (Boudker et al., 2007; Groeneveld 
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and Slotboom, 2010; Guskov et al., 2016). GltPh and 
GltTk share high sequence identity with each other 
(77%) and with EAATs (∼36%), with even higher con-
servation of amino acid residues involved in substrate 
binding (Boudker et al., 2007; Jensen et al., 2013; Sil-
verstein et al., 2015). Structural studies of the archaeal 
GltPh and GltTk proteins have provided major insight 
into the transport mechanism of glutamate transport-
ers. Recently, crystal structures of human EAAT1 have 
also been solved, revealing the architecture of the eu-
karyotic homologue (Canul-Tec et al., 2017).
Crystal structures overview
Glutamate transporters are homotrimeric proteins (Yer-
nool et al., 2003, 2004; Gendreau et al., 2004; Canul-Tec 
et al., 2017), which had already been established for 
several family members before the first crystal structure 
was solved. Each subunit of the trimer has a complex 
topology of eight transmembrane helical segments 
(TMS1–8) and two helical hairpins (HP1 and HP2) that 
form two domains: a scaffold domain (TMS1, TMS2, 
TMS4abc, and TMS5), which is involved in trimeriza-
tion, and a transport domain (TMS3, TMS6, HP1, 
TMS7ab, HP2, and TMS8), which contains the substrate 
and cation-binding sites (Fig. 2). Structural differences 
between the archaeal transporters and the human 
EAAT1 include deletions and insertions, as well as di-
vision of TMS1 into two and TMS8 into three separate 
helices, TMS1ab and TMS8abc, respectively.
Derivation of a mechanistic model of transport of 
the archaeal transporters has greatly benefited from 
crystal structures in different states, such as apo, sub-
strate-bound, occluded binding site, and exposed bind-
ing site. Alternative access of the substrate-binding site 
to either side of the membrane is achieved via an ele-
vator mechanism (for a review see Drew and Boudker, 
2016; Ji et al., 2016; Ryan and Vandenberg, 2016), in 
which the transport domains move up and down relative 
to the trimerization domains, which are anchored in the 
membrane. The GltPh transporter has been crystallized 
with the transport domain in the outward-facing con-
formation (OFC) and the inward-facing conformation 
(IFC), with the substrate-binding site located close to the 
extracellular or cytoplasmic space, respectively (Table 1 
and Fig.  2, D and E; Yernool et al., 2004; Boudker et 
al., 2007; Reyes et al., 2009, 2013; Verdon and Boudker, 
2012; Verdon et al., 2014; Akyuz et al., 2015). Compar-
ison of the GltPh structures in the OFC and IFC showed 
that both scaffold and transport domains are relatively 
rigid bodies that stay largely unchanged during the ele-
vator-like movement (Reyes et al., 2009). Transfer of the 
transport domain is made possible by hinge movements 
in the short loops 2–3 and 5–6. As a result, the transport 
domain undergoes a transition of 16–18 Å toward the 
cytoplasm, accompanied by a rotation of ∼37°.
Amino acid residues implicated in substrate and ion 
binding are highly conserved among glutamate trans-
porters (Fig.  2  C; Boudker et al., 2007; Jensen et al., 
2013). The substrate-binding site is formed by tips of HP1 
and HP2, the unwound part of TMS7, and the central 
part of TMS8. In the OFC, helical hairpin HP2 occludes 
the bound substrate from the solvent in GltPh, GltTk, and 
EAAT1. The IFC structures of GltPh showed a highly 
similar occluded conformation of the substrate-binding 
site. In this occluded state, the tips of structurally re-
lated HP1 and HP2 seal off the binding site.
Figure 1. Schematic representation 
of the glutamate transporter trans-
port cycle. (A) EAATs couple glutamate 
uptake to symport of three sodium ions 
and one proton and to antiport of one 
potassium ion. (B) The archaeal homo‑
logues GltTk and GltPh couple aspartate 
uptake only to symport of three sodium 
ions. Both mammalian and archaeal 
homologues were shown to support 
chloride conductance uncoupled to 
substrate transport. One protomer of 
the homotrimeric protein is depicted 
schematically in the membrane plane. 
The scaffold and transport domains are 
shown in yellow and blue, respectively; 
the position of membrane is indicated 
with the black lines, where “in” and 
“out” stand for inside and outside the 
cell, respectively. Sodium (magenta), 
proton (dark green), chloride (gray), and 
potassium (light green) ions are shown 
as circles, and substrate as a purple tri‑
angle. Possible chloride ion pathway is 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Crystallization of GltPh in the OFC with the com-
petitive inhibitor TBOA (d,l-threo-β-benzyloxyaspar-
tate) revealed an open conformation of hairpin HP2, 
which had shifted ∼10 Å in the direction of the 3–4 
loop from its position in aspartate-bound GltPh (Boud-
ker et al., 2007). The HP2 opening was explained by 
steric clashes with the benzyl group of the inhibitor 
modeled to the structure. Although this explanation 
is reasonable, it is important to note that the GltPh-
TBOA structure did not reveal electron density for the 
benzyl group of the inhibitor (see section TBOA bind-
ing and Fig. 6).
It was initially proposed for GltPh that HP2 would be 
mainly open in the apo state and that aspartate bind-
ing causes its closure. However, the first structure of 
the substrate-free transporter solved for the homologue 
GltTk revealed an OFC with occluded binding site and 
closed HP2 (Jensen et al., 2013). A structure of the sub-
strate-free GltPh mutant R397A in OFC in the absence 
of sodium ions also showed an occluded conformation 
with HP2 in the closed state. The use of the R397A mu-
tant was necessary to determine the structure of GltPh 
in apo form, because it has lower affinity for l-aspartate 
(6.6 µM vs. 27 nM for wild type; Verdon et al., 2014). 
The occluded apo state is probably required to reorient 
the transport domain from the IFC to the OFC during 
the transport cycle.
The structure of GltPh mutant R397A crystallized in 
the presence of sodium, but absence of aspartate was 
similar to the structure of aspartate-bound GltPh, except 
that the HP2 tip was slightly open (Verdon et al., 2014), 
with a proposed displacement of ∼3 Å. However, the 
low resolution of the structure and absence of electron 
density for sodium ions (see section Cation-binding sites 
and Fig. 4) make it difficult to draw solid conclusions.
A structure of the GltTk homologue revealed the po-
sitions of all three sodium-binding sites (Guskov et al., 
2016). The sites of two of the sodium ions (Na1 and 
Na2) correspond to the sites found earlier in the struc-
ture of GltPh crystallized with thallium ions (Boudker 
et al., 2007). The assignment of the third sodium ion 
allowed further insight into the mechanism of sodium 
and aspartate coupling during the transport (Guskov 
et al., 2016). It should be noted that the presence of 
a bound sodium ion usually cannot be established un-
equivocally based on the electron density alone because 
the number of electrons of a sodium ion is identical to 
that of a water molecule. Therefore, additional indica-
tors such as geometry of the site, distances and angles, 
or alternative experiments are required for the assign-
Figure 2. Structural architecture of the glutamate transporter homologues. (A) Extracellular view of the GltTk homotrimer; 
cartoon representation. The scaffold and transport domains of one of the protomers are shown in yellow and blue, respectively. 
(B) Cross‑section of the GltTk trimer in the OFC (left) and GltPh in the IFC (right); protein in surface representation, the position of 
membrane indicated with the black lines. (C) Substrate‑binding site in GltTk (residue numbering for GltPh in parentheses). l‑Aspartate 
(black) and amino acid residues involved in substrate coordination are shown as sticks and sodium ions as purple spheres. HP1 and 
HP2 are shown in cyan and green, respectively. (D and E) Cartoon representation of protomers in OFC (D) and IFC (E). Color scheme 
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ment. The GltTk structures also allowed description of 
the long extracellular loop between TMS3 and TMS4 
(Guskov et al., 2016) that plays an important role in the 
transport process (Compton et al., 2010). This loop was 
shown to cover the outer face of the transport domain 
in such a way that it might restrict movements of HP2 
within the substrate-binding pocket.
Recent crystal structures of human EAAT1 provided 
the first insight into the structure of the eukaryotic glu-
tamate transporters (Canul-Tec et al., 2017). EAAT1 
was crystallized in the OFC in complex with l-aspartate, 
and in the presence of allosteric and competitive inhib-
itors. The noncompetitive EAAT1-selective inhibitor 
UCPH101 (2-amino-4-(4-methoxyphenyl)-7-(naphtha-
len-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-car-
bonitrile) was bound at the interface of transport and 
scaffold domains in a hydrophobic pocket between 
TMS3, TMS7, and TMS4c, more than 15 Å away from 
the substrate/sodium-binding pocket (Canul-Tec et al., 
2017). Crystallization of EAAT1 with the TBOA deriva-
tive TBOATFB (4-(trifluoromethyl)benzoylamino]benzy-
loxy]aspartate) showed a similar open conformation of 
HP2 as found in the GltPh-TBOA model, but some care 
needs to be taken in interpretation of the electron den-
sity (see section TBOA binding).
Structural data quality indicators
The quality of crystal structures directly depends on 
the quality of the x-ray diffraction data that were used 
for their determination. Several articles and reviews de-
scribe valuable tools for evaluation of raw experimental 
data and solved macromolecular structures (Kleywegt, 
2000; Wlodawer et al., 2008; Chen et al., 2010; Gore et 
al., 2012; Adams et al., 2016; Wlodawer, 2017).
Two general indicators for the quality of diffrac-
tion data are resolution and data completeness. Res-
olution defines the level of detail that can be seen in 
electron-density maps. Generally, resolutions of ∼4 Å 
allow only backbone tracing and visualizing secondary 
structure elements (α-helices are often much better de-
fined than β-strands). The assignment of side chains at 
low resolution is usually not possible, and the confor-
mations of side chains in deposited models should be 
treated with caution. In structures solved at resolutions 
between 3 and 4 Å, the fold is typically described cor-
rectly, even though there is a considerable probability 
of erroneous assignments and wrong conformations of 
many side chains. Electron densities at 2.5–3-Å resolu-
tion usually allow for unambiguous assignment of the 
main chain and side chains for the rigid parts of a pro-
tein; however, in more flexible parts of a molecule, the 
probability of incorrectly placed side chains is still high. 
Ligands that fully occupy their binding sites usually are 
possible to visualize at this resolution, as well as highly 
ordered water molecules. At higher resolutions of 2– 
2.5 Å, auto-building procedures (Cowtan, 2006; Terwil-
liger et al., 2008) and experienced crystallographers 
are capable of building a (nearly) complete model and 
including most of the ordered solvent molecules and 
ligands in the correct conformations (Blow, 2002).
Most of the GltPh structures were determined using 
crystals that diffracted to a moderate resolution of 3–4 
Å (Table  1). Both structures of GltPh with protomers 
containing transport domains in intermediate positions 
(Protein Data Bank [PDB] codes 3V8G and 4X2S), as 
well as GltPh structures in OFC (4IZM and 4OYE) and 
IFC (4P6H), have resolution lower than or equal to 4 Å.
It is important to note that judging a crystal structure 
by resolution only is not good practice and could be 
misleading. Apart from the checking additional quality 
indicators (see below in this section), the electron-den-
sity maps should always be manually inspected. Often, 
moderate- and low-resolution structures provide elec-
tron-density maps of adequate quality to provide reli-
able insight in the general architecture, as well as some 
details of the macromolecule (still depending on the 
resolution). Conversely, models solved from data col-
lected at high (atomic) resolution can have serious 
errors caused, for example, by insufficient complete-
ness of data or inappropriate refinement protocols 
(Afonine et al., 2012).
Completeness of data can be defined by the number of 
collected crystallographic reflections in comparison to 
the number of theoretically possible reflections unique 
for the given crystal symmetry. For reliable refinement 
and model building, the overall completeness should 
be desirably higher than 90%, and values less than 80% 
(McRee, 1993) are considered poor. Because all reflec-
tions contribute to calculation of the electron-density 
map, the quality of maps calculated from incomplete 
data will be poor (Wlodawer et al., 2008). Table 1 shows 
structures that were solved from incomplete datasets 
(PDB codes 2NWL, 2NWX, 2NWW, 3V8G, 4P6H, 4OYE, 
5DWY, and 5LM4).
Again, careful inspection of the electron-density 
maps is highly recommended to estimate the quality of 
the structural model. As an example, we compared the 
quality of the electron-density maps of two GltPh struc-
tures in which the transport domain is in neither the 
OFC nor the IFC, but in an intermediate state (PDB 
codes 3V8G and 4X2S, with resolutions of 4.21 and 4.66 
Å, respectively) with that of GltTk (2.70-Å resolution). 
Fig. 3 shows electron densities for the highly conserved 
NMD GT motif, which is located in the unbound re-
gion of TMS7 and involved in formation of the sub-
strate-binding and sodium ion–binding sites. The poor 
electron densities for both GltPh structures in the inter-
mediate states indicate a high chance of misinterpreta-
tion. Additionally, the low overall completeness (73.1% 
for the intermediate OFC) of the structural data affects 
the reliability of the model. It should be noted that the 












main is in an intermediate state is probably not affected 
by the data quality, but the details of the models should 
be treated with care.
The collected diffraction data (intensities of reflec-
tions) and the indirectly derived phases (see Glossary) 
are used to generate an electron-density map, which is 
used to build an initial protein model. Further crystallo-
graphic refinement includes multiple corrections of the 
model and improving phases to obtain the best agree-
ment between the reflection amplitudes observed in 
experiment (Fo) and calculated from the model (Fc). 
This agreement is monitored with the so-called R-factor 
(or Rwork), calculated as  Σ   | Fo  –  Fc | / ΣFo . As cross-vali-
dation, an additional R-factor (Rfree) is calculated using 
∼5–10% of the reflections randomly chosen from the 
dataset and never included in the refinement process 
(Brünger, 1992). A low value of Rfree is the most com-
mon indicator of successful refinement (the lower the 
value, the better the fit between the experimental data 
and the model). Comparing the values of Rwork and Rfree 
makes it possible to assess potential overfitting. There 
is a quasilinear relation between the difference be-
tween Rfree and Rwork resolution. Rfree − Rwork differences 
for structures determined at 3–4-Å resolution should 
be ∼5%, and differences of less than 2% correspond 
to structures solved at resolution higher than 1 Å (Ur-
zhumtsev et al., 2009).
The final structural model must conform to physical 
and chemical rules: the model must have reasonable 
crystal packing of molecules, contacts, and solvent con-
tent; correct stereochemistry; and correct bond lengths 
and angles. Furthermore, a model should have reason-
able values for the crystallographic validation criteria: 
R-factors, B-factors (or displacement parameters which 
are commonly referred to as temperature factors), 
clash score (atomic overlaps), and Ramachandran out-
liers (torsion angles that fall into disallowed areas of a 
Ramachandran plot; Ramachandran et al., 1963), and 
it should have a best fit to an electron-density map. 
Altogether, these parameters are used to analyze the 
structure quality. While analyzing structural statistics 
of glutamate transporter homologue structures, we ob-
served that the PDB entries 1XFH, 2NWW, 3KBC, 3V8F, 
4P3J, 4OYE, and 4OYF show a very small difference be-
tween Rwork and Rfree factors, which might indicate that 
the data that were set aside for Rfree calculation were 
used at some stage of refinement (Wlodawer et al., 
2008; Wlodawer, 2017), and thus could indicate possi-
ble overfitting.
Analysis and validation of structures
Appreciation of the limitations of these structural mod-
els will help prevent the generation of hypotheses and 
follow-up experiments for which there is no solid basis. 
Next, we discuss GltPh structures in which sodium/potas-
sium binding sites are interpreted (PDB codes 2NWX, 
4P1A, and 4OYF), the TBOA-bound structure (PDB 
code 2NWW) and structures in which the transport do-
main is in neither the OFC nor the IFC, but in an in-
termediate state (PDB codes 3V8G and 4X2S; Table 1). 
The quality of the crystallographic data for these struc-
tures might have affected mechanistic interpretations.
Cation-binding sites. Difficulties in obtaining high-reso-
lution GltPh structures prevent visualization of sodium 
ions involved in transport. To model the positions of 
sodium-binding sites in GltPh, thallium, which provides 
a strong anomalous signal, was used in crystallization 
experiments (Boudker et al., 2007; Verdon et al., 2014). 
This approach allowed for identification of the loca-
tions of sodium-binding sites Na1 and Na2, that were 
later observed in other crystal structures (Table 1), mo-
lecular simulations, and electrostatic calculation studies 
(Huang and Tajkhorshid, 2008; Gu et al., 2009; Holley 
and Kavanaugh, 2009; Larsson et al., 2010; Scopelliti et 
al., 2014), whereas for the Na2 site, other positions were 
also suggested (Gu et al., 2009; Heinzelmann and Kuyu-
cak, 2014; Venkatesan et al., 2015).
Figure 3. Examples of electron densities 
for GltTk and GltPh structures. (A–C) Rep‑
resentation of electron densities for the 
conserved NMD GT motif (shown as sticks) 
in the following structures: (A) GltTk OFC 
(PDB code 5DWY); (B) GltPh iOFC (PDB 
code 3V8G); and (C) GltPh with asymmetric 
IFC protomers (PDB code 4X2S). The 2Fo‑
Fc electron‑density maps (shown in blue 
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In the crystal structure of the GltPh mutant R397A 
(PDB code 4OYF), sodium ions were placed in the Na1 
site. However, the absence of electron density in the 
map indicates that the sodium ion might have been 
placed incorrectly (Fig. 4). Moreover, in the substrate/
sodium-binding site, the model does not fit properly 
in the density map. Assignment of water molecules 
at resolution 3.41 Å also seems inappropriate. In ad-
dition, the structural statistics of these data show an 
extremely small difference between R-factors (0.9%). 
All in all, the moderate data quality does not seem to 
provide a solid basis for the interesting suggestion that 
opening of the HP2 tip after sodium binding can be a 
mechanism preventing uncoupled uptake of sodium 
ions (Verdon et al., 2014). Furthermore, such a small 
movement of the HP2 loop (∼3 Å) in the medium-res-
olution structure could also be an over-interpretation, 
especially taking into account the significant coordi-
nate error at this resolution.
Almost identical conformations of the GltPh OFC 
structures in the apo state and in the presence of so-
dium ions suggest minor conformational changes 
upon sodium binding to the apo protein. This result 
contrasts with electron paramagnetic resonance (EPR) 
and fluorescence data showing that sodium binding to 
the aspartate-free GltPh is followed by large conforma-
tional changes (Hänelt et al., 2013, 2015). Therefore, 
high-quality crystal structures of the transporter in the 
sodium-only state are needed to properly assess the con-
formation. The same applies for the GltPh structures in 
the IFC form in the presence of sodium ions, where the 
moderate resolution of 3.25–4.08 Å prevented visualiza-
tion of relatively small conformational changes in the 
substrate-binding site.
Countertransport of a potassium ion is required 
for relocation of eukaryotic glutamate transporters to 
the outward-facing state. The position of the potassi-
um-binding site was studied by mutational and compu-
tational studies (Kavanaugh et al., 1997; Zarbiv et al., 
1998; Zhang et al., 1998; Bendahan et al., 2000; Rosen-
tal et al., 2006, 2011; Holley and Kavanaugh, 2009; Tao 
et al., 2010; Mwaura et al., 2012; Heinzelmann and 
Kuyucak, 2014), but the crystal structures of EAAT1 
did not reveal potassium-binding sites (Canul-Tec et 
al., 2017). Although GltPh does not transport potas-
sium ions (Raunser et al., 2006; Ryan et al., 2009), it 
was used for studies of countertransport because of 
structural similarity with EAATs. Soaking of the IFC 
apo-GltPh crystals with thallium ions revealed a new 
possible cation-binding site that overlaps with the aspar-
tate-binding site (Verdon et al., 2014). Fig. 5 represents 
electron density in the suggested potassium-binding 
site (PDB code 4P1A, 3.75-Å resolution). For all three 
protomers, the difference map at 3σ shows negative 
density, indicating inappropriate refinement of occu-
pancies or B-factors and/or severe radiation damage. 
It is possible that the mentioned cation-binding site 
is either an experimental artifact or a transition site 
of a sodium ion.
Figure 4. Absence of electron density in the Na1 site for the 
apo GltPh structure (PDB code 4OYF). The electron‑density 
map (2Fo‑Fc) is shown as a blue mesh and contoured at 1σ. The 
Fo‑Fc map is colored in green (3σ) and red (−3σ). See Glossary 
for explanation of 2Fo‑Fc and Fo‑Fc maps. Cartoon represen‑
tation; sodium ion Na1 assigned in this structure is shown as a 
purple sphere, and amino acid residues supposedly involved in 
its coordination are shown as sticks.
Figure 5. Representation of the electron density for the 
thallium ions in the suggested cation-binding site (TlCt) and 
Na2 site (Tl2) of GltPh (PDB code 4P1A). The 2Fo‑Fc map is 
colored in blue and contoured at 3σ. The Fo‑Fc map is colored 
in green and red (±3σ). Difference maps are used to check the 
fit of the model to the diffraction data (see Glossary). The Fo‑Fc 
difference map is a tool to visualize possible misfits and errors: 
positive peaks (green) indicate missing parts of the model, and 
negative peaks (red) indicate that these parts of the model are 
not supported by experimental data, and hence have to be 
removed. Additionally, negative density peaks might indicate 
inappropriate refinement of occupancies/B‑factors and/or se‑
vere radiation damage. Cartoon representation; thallium ions 












TBOA binding. TBOA is a competitive blocker of eu-
karyotic glutamate transporters (Shimamoto et al., 
1998), and the structure of archaeal GltPh with TBOA 
revealed a movement of HP2 hairpin, providing a possi-
ble explanation of the inhibition mechanism (Boudker 
et al., 2007). Modeling of the inhibitor was based on the 
anomalous difference map calculated from diffraction 
data of the GltPh complex with 3-Br-TBOA, which re-
veals the position of the bromine atom. However, direct 
evidence based on electron density of the orientation of 
the full TBOA molecule in this structure is absent. Anal-
ysis of the GltPh TBOA structure (PDB code 2NWW) 
showed peaks of negative electron density for the bulky 
benzyl group of the inhibitor (Fig. 6). We calculated an 
electron-density omit map for the model and showed 
that the benzyl group of the blocker does not fit in the 
electron density. Instead, there might be an alternative 
possible orientation of the bound TBOA (Fig. 6) that 
could also cause displacement of HP2. Similar to GltPh, 
an opening of HP2 was observed in the structure of 
human EAAT1 with TBOATFB (PDB code 5MJU), where 
the position of the bound TBOA derivative also requires 
additional experimental confirmation.
Intermediate-state structures. We analyzed the electron 
densities of GltPh structures in intermediate states (PDB 
codes 3V8G and 4X2S). The structure of the GltPh 
V198C/A380C mutant showed an intermediate OFC 
(iOFC), where the transport domain of one of the 
protomers was shifted ∼3.5 Å toward the cytoplasm and 
rotated ∼15°, suggesting that during the inward move-
ment, rotation of the transport domain precedes its in-
ward translation (Verdon and Boudker, 2012). The 
structure of GltPh mutant R276S/M395R showed an-
other asymmetric arrangement of protomers. The 
transport domain of one of the protomers was shifted 2 
Å further inward and rotated by 7° (IFC locked config-
uration) in comparison with the original structure of 
GltPh in the IFC (mutant K55C/A364C), whereas the 
transport domains of the other two protomers moved 
from the scaffold domain by ∼12° (IFC unlocked con-
figuration) compared with the locked protomer 
(Akyuz et al., 2015).
The difficulties in obtaining crystal structures in inter-
mediate states and the moderate quality of the available 
GltPh structures most likely are caused by high hetero-
geneity of the transporter conformations together with 
short lifetimes of the intermediates. The crystal lattice 
might be a factor that limits the number of observed 
conformations of the transporter. The presence of al-
most identical structures of GltPh for the two extreme 
states solved from crystals with different crystal packing 
(six space groups for outward-facing conformation P 1 
21 1, C 1 2 1, P 31, P 32 2 1, P 61, and P 63 and two space 
groups for inward-facing conformation C 1 2 1 and C 2 2 
21) gives credibility to the functional relevance of these 
conformations. In addition, the existence of these states 
is consistent with a plethora of other data (Akyuz et al., 
2013, 2015; Erkens et al., 2013; Georgieva et al., 2013; 
Hänelt et al., 2013; Ruan et al., 2017). However, the two 
structures of GltPh in different intermediate states (in 
space groups C 1 2 1 [iOFC] and P 65 2 2 [IFC locked 
and unlocked protomers]) may be affected by crystal 
packing. The crystals of GltPh in the iOFC state (Verdon 
and Boudker, 2012) show contacts of the transport do-
main with symmetry molecules. Crystal contacts could 
also contribute to the stabilized (or forced formation) 
of the observed unlocked IFC state (PDB code 4X2S). 
The unlocked protomers (chains B and C) seem to have 
different crystal-packing environments than the sin-
gle locked protomer (Fig. 7). Because of steric clashes 
between loop 4c-5 (chain B) and helix HP1b (chain 
Csym) the 4c-5 hairpin is shifted in comparison with the 
locked chain. Therefore, the unlocked protomers from 
symmetry molecules could stabilize each other in the 
crystal lattice.
Conclusion and outlook
Intensive structural studies of glutamate transporter 
homologues have provided fundamental insight into 
protein architecture and transport mechanisms. Many 
interpretations of the determined structures are ex-
Figure 6. Absence of electron density for the benzyl group 
of TBOA in the GltPh structure (PDB code 2NWW). Possible 
alternative orientation of the benzyl group of TBOA (shown 
with an arrow). The electron‑density omit map is shown in gray 
mesh (1σ). The Fo‑Fc map is colored in green (3σ) and red (−3σ). 
Cartoon representation. HP2 loop is shown in purple. TBOA 
(shown in black) and residues involved in its binding are pre‑
sented as sticks. Omit maps are used to remove bias (largely 
introduced by molecular replacement, where phases are taken 
from the similar structure, or caused by erroneous modeling) 
and can be used to verify assignment of ligands in binding sites. 
This is achieved by excluding a part of the model from the re‑
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tremely valuable and have greatly expanded our insight 
into membrane protein conformational changes. None-
theless, some conclusions based on moderate-quality 
data might be over-interpretations.
The availability of similar crystal structures obtained 
for different crystallization conditions of different ho-
mologue proteins (GltPh, GltTk, EAAT1), with crystals of 
different space groups, as well as agreement with bio-
physical experiments (Akyuz et al., 2013, 2015; Erkens 
et al., 2013; Ruan et al., 2017), indicate the relevance 
of the OFC and IFC structural models. EPR studies 
showed that GltPh is conformationally heterogeneous, 
in both detergent micelles and lipids (Georgieva et al., 
2013; Hänelt et al., 2013). However, a high-resolution 
interpretation of the structural heterogeneity is lacking. 
Unfortunately, the moderate quality of GltPh structures 
in intermediate states and potential crystal-packing ef-
fects diminish their usefulness.
The l-aspartate–binding site is well characterized in 
several GltPh, GltTk, and EAAT1 structures (Table  1), 
and the positions of all three sodium ions were found 
in the GltTk OFC structure (Guskov et al., 2016). Lack 
of detailed structures hampers the determination of 
the position of sodium ions and subtle transitions in 
the substrate-binding site of IFC structures. Determi-
nation of high-quality structures of the proteins in the 
presence of sodium alone will be necessary to provide 
better insight into the sodium coupling mechanism. 
Crystal structures with resolution of 2.5 Å or higher are 
necessary for unambiguous determination of positions 
of water molecules in the binding site, which is import-
ant for performing molecular simulations and under-
standing the influence of solvent on substrate/sodium 
coupling. Obtaining high-resolution structures of glu-
tamate transporter homologues in different states and 
the combination of x-ray crystallography with molecu-
lar simulations and such techniques as single-molecule 
fluorescence resonance energy transfer (smFRET) and 
atomic force microscopy (AFM) should reveal gating 
events of transport cycle that still remain unclear.
The critical evaluation performed in this viewpoint 
is aimed to emphasize that care should be taken when 
using medium-quality structures as an input for further 
experiments, such as molecular dynamic simulations, 
EPR studies, and drug design. When using the structures 
of GltPh in intermediate states, it is necessary to remem-
ber that crystal contacts could stabilize these conforma-
tions, and transport domains do not obligatorily pass 
these states while traversing the membrane. Similarly, 
metal cations that were placed in the deposited struc-
tural models solely on the basis that they theoretically 
should have been there, but for which experimental ev-
idence such as electron density was lacking, should be 
treated with the utmost caution. The exact positions of 
the TBOA ligand and its derivative were not entirely de-
termined based on electron density, which, for instance, 
will affect structure-based design of new inhibitors.
It is also important to realize that many of the solved 
crystal structures were not of the wild-type protein but of 
mutants that behaved better in expression, purification, 
and crystallization. The highest-resolution structures of 
the glutamate transporter homologues are reported for 
the GltTk wild-type protein (Jensen et al., 2013; Guskov 
et al., 2016; although even in this case, the protein has 
an extra His-tag). Because crystallization of the wild-type 
GltPh did not succeed, all GltPh structures were obtained 
for the mutant proteins, with at least seven point sub-
stitutions of nonconserved amino acid residues. These 
mutants had a higher expression level and crystallized 
more successfully than the wild-type GltPh (Yernool et 
al., 2004). Because of difficulties in purification of the 
wild-type EAAT1, thermostabilized versions of the pro-
tein were used for crystallization that share an overall 
sequence identity of ∼75% with the wild type and up 
to ∼90% identity at the substrate- and sodium-binding 
sites. In total, 73–76 mutations were introduced to in-
crease protein stability and obtain functionally active 
protein (Canul-Tec et al., 2017). Although the function 
of the mutants appears to be largely unaffected com-
pared with the wild-type protein, there may be yet-un-
detected functional differences.
Finally, as with any other structure deposited into the 
PDB database, one should remember that a structure is 
always a user interpretation of experimental data, and 
Figure 7. Contacts between GltPh asymmetric IFS protomers 
related by noncrystallographic symmetry (PDB code 4X2S). 
Superposition of unlocked protomers B (green) and C (gray) 
and a locked protomer A (yellow). Chain Csym of a symmetry 
molecule that forms an interface with chain B is shown in blue. 
Chains B and Csym are symmetry mates, where steric clashes 
between the loop 4c‑5 (chain B) and helix HP1b (chain Csym) 
may have caused the shift of 4c‑5 hairpin (shown with a dashed 
arrow), creating an “unlocked” conformation. Cartoon repre‑
sentation; amino acid residues that could cause steric clashes 












it is prone to contain (some) errors. Therefore, the 
model should not be taken for granted, but the under-
lying data (including the electron-density map) should 
be explored and checked before planning new experi-
ments to test hypotheses, or when using the models for 
explanations of biological functions.
Glossary
Reflections are defined as regularly spaced spots with 
varying intensities recorded on a detector as a result 
of x-rays scattering by a crystal. To generate an elec-
tron-density map, not only the amplitudes but also the 
phases are needed. Phases cannot be recorded during 
experiment, which is known as the phase problem. 
Phases can be obtained either via single (or multiple) 
isomorphous replacement (SIR/MIR), when a heavy 
atom is introduced into a crystal and then diffraction 
from a derivative crystal is compared with the one of a 
native crystal, and using direct methods to determine 
the positions of heavy atoms, which in turn helps to es-
timate phases; or by using anomalous x-ray scattering 
(single-wavelength anomalous diffraction [SAD] or 
multi-wavelength anomalous dispersion [MAD]) when 
an introduction of a heavy atom causes a phase shift 
(anomalous dispersion) used to estimate phases; or by 
using initial phases from a structurally similar protein 
(molecular replacement).
The electron-density map is the direct result of a crys-
tallographic experiment and is a three-dimensional de-
scription of the electron density of the molecules in a 
crystal. A structural model of the molecules is built to fit 
the electron density.
After generating the initial electron-density map and 
building a starting model, structural refinement takes 
place, which aims to improve the phases and find the 
best agreement between the measured data and the 
constructed model.
Resolution (in crystallography) is a measure of details 
that can be distinguished in an electron-density map; 
measured in angstroms (1 Å = 0.1 nm).
Difference electron-density maps are used to check 
the fit of the model to the diffraction data. The 2Fo-
Fc map is a composite map that is commonly used as a 
working map against which the model is checked. The 
Fo-Fc map is a tool to visualize possible misfits and er-
rors. Omit maps are used to minimize the model bias 
and are particularly useful to verify assignment of li-
gands in binding sites. Maps are typically countered at 
different levels of sigma (σ), which is referred to as the 
standard deviation. The typical sigma value for a 2Fo-Fc 
map is 1σ, and for a Fo-Fc map, 3σ.
R-factor, or Rwork, is a measure of the agreement be-
tween the collected diffraction data and the model.
B-factor, or atomic displacement parameter (ADP), 
measures the displacement of an atom caused by ther-
mal fluctuations, conformational disorder, and crystal 
lattice disorder. It is useful to detect the mobile por-
tions of a model.
Occupancy of a given atom shows the fraction of 
molecules (from 0 to 1.00) in the crystal in which this 
particular atom actually occupies the position speci-
fied in the model.
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